Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
rhGH and Vaccination in HIV-1 Infected Patients
NCT00287677Phase 4Completed
- Sponsor
- Hospital Universitari Germans Trias i Pujol
- Start
- Jan 2006
- Primary completion
- Jul 2009
- Modality
- Hormone, rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of somatropin in human immunodeficiency virus infection (HIV) (4 arms), sponsored by Hospital Universitari Germans Trias i Pujol. Primary endpoint: Proportion of patients HIV+ that recover the immunospecific responses against tetanus toxoid and Hepatitis A at 24 weeks. Started Jan 2006; status: completed.
02
Drugs
somatropin
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00287677.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00287677.